It looks like the information in the quarterly is attracting some interest in the company and finally starting to move the share price. The market maybe seeing just how undervalued this company currently is.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025